BankChampaign National Association’s Eton Pharmaceutcials ETON Stock Holding History

BankChampaign National Association’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Buy	+5,590	New	+$164K	0.16%	155

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

BankChampaign National Association's ETON Position: Q2 2026 in Review

BankChampaign National Association opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 5,590 shares worth $202K. The stake represents 0.16% of the portfolio and ranks #155 among its holdings.

165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

BankChampaign National Association held 5,590 shares of Eton Pharmaceutcials worth $202K as of Q2 2026.
Eton Pharmaceutcials was a new BankChampaign National Association position in Q2 2026.
Eton Pharmaceutcials made up 0.16% of BankChampaign National Association's portfolio in Q2 2026, its #155 holding.
165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on BankChampaign National Association's 13F filing for Q2 2026, filed 23 Jul 2026.